Total Payments
$5,303
2024 Payments
$576.52
Companies
41
Transactions
331
Medicare Patients
3,082
Medicare Billing
$260,427
Payment Breakdown by Category
Food & Beverage$5,303 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,303 | 331 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $799.17 | 50 | $0 (2024) |
| Novo Nordisk Inc | $695.84 | 47 | $0 (2024) |
| Lilly USA, LLC | $551.66 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $389.18 | 20 | $0 (2024) |
| Amarin Pharma Inc. | $275.35 | 13 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $229.73 | 16 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $222.97 | 11 | $0 (2022) |
| GlaxoSmithKline, LLC. | $222.76 | 14 | $0 (2024) |
| Allergan, Inc. | $219.57 | 14 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $200.46 | 14 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $576.52 | 31 | Novo Nordisk Inc ($159.66) |
| 2023 | $374.27 | 22 | Novo Nordisk Inc ($148.97) |
| 2022 | $158.29 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($82.15) |
| 2021 | $774.73 | 49 | Amarin Pharma Inc. ($83.17) |
| 2020 | $914.22 | 54 | Amarin Pharma Inc. ($137.36) |
| 2019 | $812.14 | 53 | Novo Nordisk Inc ($149.44) |
| 2018 | $726.76 | 49 | AstraZeneca Pharmaceuticals LP ($178.03) |
| 2017 | $965.82 | 65 | AstraZeneca Pharmaceuticals LP ($208.79) |
All Payment Transactions
331 individual payment records from CMS Open Payments — Page 14 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/21/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: OBESITY | ||||||
| 01/13/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Diabetes | ||||||
| 01/12/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/11/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/04/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 774 | 1,194 | $225,994 | $67,637 |
| 2022 | 10 | 666 | 957 | $202,526 | $59,195 |
| 2021 | 14 | 793 | 1,173 | $184,353 | $70,121 |
| 2020 | 16 | 849 | 1,353 | $185,711 | $63,475 |
Total Patients
3,082
Total Services
4,677
Medicare Billing
$260,427
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 355 | $117,150 | $27,374 | 23.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 99 | 99 | $33,363 | $12,234 | 36.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $17,952 | $6,770 | 37.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 75 | 75 | $16,200 | $5,656 | 34.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 70 | 71 | $9,952 | $5,093 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 71 | $16,543 | $3,752 | 22.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 72 | 73 | $2,482 | $2,154 | 86.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,708 | $1,742 | 37.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 87 | 87 | $4,176 | $1,530 | 36.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 23 | 23 | $920.00 | $678.73 | 73.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 50 | $1,800 | $484.65 | 26.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 27 | 172 | $344.00 | $123.37 | 35.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 11 | $44.00 | $37.51 | 85.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 18 | 72 | $360.00 | $6.20 | 1.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 382 | $126,060 | $29,947 | 23.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 84 | 84 | $28,308 | $10,688 | 37.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 80 | 82 | $11,376 | $5,535 | 48.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 74 | 74 | $15,984 | $5,432 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 60 | $13,980 | $3,467 | 24.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 83 | 85 | $2,890 | $2,415 | 83.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 64 | 64 | $3,072 | $1,140 | 37.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 15 | 15 | $600.00 | $428.31 | 71.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 15 | 94 | $188.00 | $83.63 | 44.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 16 | 17 | $68.00 | $58.55 | 86.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 182 | 429 | $105,162 | $34,914 | 33.2% |
About Dr. Jeffrey Mcdaniel, M.D
Dr. Jeffrey Mcdaniel, M.D is a Sports Medicine healthcare provider based in Midlothian, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366576282.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Mcdaniel, M.D has received a total of $5,303 in payments from pharmaceutical and medical device companies, with $576.52 received in 2024. These payments were reported across 331 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,303).
As a Medicare-enrolled provider, Mcdaniel has provided services to 3,082 Medicare beneficiaries, totaling 4,677 services with total Medicare billing of $260,427. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine
- Location Midlothian, TX
- Active Since 03/15/2007
- Last Updated 04/20/2021
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1366576282
Products in Payments
- FARXIGA (Drug) $634.76
- JARDIANCE (Drug) $431.67
- Vascepa (Drug) $275.35
- Ozempic (Drug) $273.70
- TRULICITY (Drug) $214.06
- UBRELVY (Drug) $157.97
- MOUNJARO (Drug) $140.06
- XARELTO (Drug) $138.84
- TRELEGY ELLIPTA (Drug) $128.64
- Victoza (Drug) $119.13
- Trintellix (Drug) $107.14
- BREZTRI (Drug) $101.93
- SOLIQUA 100/33 (Biological) $89.69
- Rybelsus (Drug) $87.03
- TRINTELLIX (Drug) $86.29
- Livalo (Drug) $82.53
- VYVANSE (Drug) $76.95
- Wegovy (Drug) $73.96
- JANUVIA (Drug) $69.38
- CONTRAVE (Drug) $68.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.